Results 151 to 160 of about 86,557 (257)
Urolithin A, a gut microbial metabolite, binds TNF to suppress proliferation, inflammation, and oxidative stress, offering a promising microbe‐derived therapeutic avenue for pulmonary hypertension. ABSTRACT Pulmonary hypertension (PH) is a complex and multifactorial disease that poses a significant clinical challenge.
Yujie Qu +8 more
wiley +1 more source
The shift towards lower-risk oral food challenges since the implementation of oral immunotherapy: a retrospective cohort study. [PDF]
Sage AP +6 more
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Dosing Reactions and Missed Doses Affect Peanut Oral Immunotherapy Outcomes. [PDF]
Olayiwola O +7 more
europepmc +1 more source
ABSTRACT Background Patients with recurrent head and neck cancer (HNC) often present with severe, persistent dysphagia and xerostomia following prior chemoradiation. Although swallowing impairments and salivary dysfunction have been reported in this population, prior longitudinal studies have not examined changes in salivary composition or how these ...
Jenni Wu +8 more
wiley +1 more source
Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen-Specific Immune Responses. [PDF]
Liong O +5 more
europepmc +1 more source
ABSTRACT Background Neoadjuvant chemoimmunotherapy is being explored in locally advanced head and neck squamous cell carcinoma (HNSCC), yet the spatial patterns of pathologic response and clinical implications remain poorly characterized. Methods A 79‐year‐old female with recurrent left oral tongue SCC (PD‐L122C3 Combined Positive Score 90) who ...
Andreja Radevic +9 more
wiley +1 more source
Successful Oral Immunotherapy (OIT) Due to Anti-IgE Protection. [PDF]
Yoosefi Moridani M, Lau S, Beyer K.
europepmc +1 more source
Non‐Metastatic Squamous Cell Carcinoma of the Oropharynx: Primary Surgery or (Chemo)radiotherapy?
ABSTRACT Background In patients with locally advanced, non‐metastatic oropharyngeal squamous cell carcinoma (OPSCC), surgery‐based and nonsurgical treatment approaches have not been adequately compared in randomized Phase III clinical trials. Current clinical guidelines recommend various surgical and nonsurgical strategies across disease stages for ...
Primož Strojan +12 more
wiley +1 more source
Goldilocks zone: Allergists' perceptions of family anxiety and investment in food allergy oral immunotherapy. [PDF]
Erol M, Kim EH, Fisher JA.
europepmc +1 more source

